Efficacy of upadacitinib vs dupilumab for moderate-to-severe atopic dermatitis: analysis of time spent in itch response state from the Heads Up study

被引：0
|
作者：
Blauvelt, Andrew [1 ]
de Bruin-Weller, Marjolein [2 ]
Kwatra, Shawn G. [3 ]
Gooderham, Melinda J. [4 ]
Kim, Brian [5 ,6 ,7 ,8 ]
Liu, Yingyi [9 ]
Chu, Alvina D. [9 ]
Ofori, Sarah [9 ]
Platt, Andrew [9 ]
Calimlim, Brian M. [9 ]
Silverberg, Jonathan, I [10 ]
机构：
[1] Oregon Med Res Ctr, Portland, OR USA
[2] Univ Med Ctr Utrecht, Dept Dermatol & Allergol, Utrecht, Netherlands
[3] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
[4] Queens Univ, Kingston, ON, Canada
[5] Icahn Sch Med Mt Sinai, Kimberly & Eric J Waldman Dept Dermatol, New York, NY USA
[6] Icahn Sch Med Mt Sinai, Mark Lebwohl Ctr Neuroinflammat & Sensat, New York, NY USA
[7] Icahn Sch Med Mt Sinai, Precis Immunol Inst, New York, NY USA
[8] Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY USA
[9] AbbVie Inc, N Chicago, IL USA
[10] George Washington Univ, Sch Med & Hlth Sci, Dept Dermatol, Washington, DC USA
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2024年 / 190卷
关键词：
upadacitinib; dupilumab; atopic dermatitis; moderate-to-severe; pruritus;
D O I：
10.1093/bjd/ljad498.031
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
526
引用
收藏
页码：II28 / II29
页数：2
相关论文
共 50 条
  • [1] EFFICACY OF UPADACITINIB VS DUPILUMAB FOR MODERATE-TO-SEVERE ATOPIC DERMATITIS: ANALYSIS OF TIME SPENT IN ITCH RESPONSE STATE FROM THE HEADS UP STUDY
    Blauvelt, Andrew
    de Bruin-Weller, Marjolein S.
    Kwatra, Shawn G.
    Gooderham, Melinda J.
    Kim, Brian
    Liu, Yingyi
    Chu, Alvina
    Oforia, Sarah
    Platt, Andrew
    Calimlim, Brian
    Silverberg, Jonathan I.
    ACTA DERMATO-VENEREOLOGICA, 2022, 102 : 21 - 21
  • [2] Upadacitinib vs. dupilumab in adults with moderate-to-severe atopic dermatitis: analysis of the Heads Up phase III trial
    Blauvelt, A.
    Teixeira, H. D.
    Simpson, E. L.
    Costanzo, A.
    De Bruin-Weller, M.
    Barbarot, S.
    Prajapati, V. H.
    Lio, P.
    Hu, X.
    Wu, T.
    Liu, J.
    Ladizinski, B.
    Chu, A. D.
    Eyerich, K.
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 (03) : E123 - E123
  • [3] Efficacy and Safety of Upadacitinib versus Dupilumab Treatment for Moderate-to-Severe Atopic Dermatitis in Four Body Regions: Analysis from the Heads Up Study
    Thyssen, Jacob P.
    Rosmarin, David
    Costanzo, Antonio
    Warren, Richard
    Chu, Chia-Yu
    Chovatiya, Raj
    Ladizinski, Barry
    Hu, Xiaofei
    Liu, Yingyi
    Calimlim, Brian
    Nduaka, Chudi
    Vigna, Namita
    Armstrong, April
    DERMATOLOGY, 2025, 241 (01) : 10 - 18
  • [4] Efficacy and safety of upadacitinib vs dupilumab treatment for moderate to severe atopic dermatitis in four body regions - Analysis from the Heads Up Study
    Thyssen, Jacob P.
    Rosmarin, David
    Costanzo, Antonio
    Warren, Richard B.
    Ladizinkski, Barry
    Hu, Xiaofei
    Nduaka, Chudi
    Vigna, Namita
    Armstrong, April
    CLINICAL AND EXPERIMENTAL ALLERGY, 2022, 52 (08): : 998 - 999
  • [5] UPADACITINIB VERSUS DUPILUMAB IN ADULTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS: ANALYSIS OF THE HEADS UP PHASE 3 TRIAL
    Blauvelt, Andrew
    Teixeira, Henrique D.
    Simpson, Eric L.
    Costanzo, Antonio
    De Bruin-Weller, Marjolein
    Barbarot, Sebastien
    Prajapati, Vimal H.
    Lio, Peter
    Hu, Xiaofei
    Wu, Tianshuang
    Liu, John
    Ladizinski, Barry
    Chu, Alvina D.
    Eyerich, Kilian
    ACTA DERMATO-VENEREOLOGICA, 2021, 101 : 62 - 62
  • [6] Efficacy of upadacitinib for moderate-to-severe atopic dermatitis: analysis of time spent in skin clearance response states from the Measure Up 1, Measure Up 2 and Heads Up studies
    Blauvelt, Andrew
    Silverberg, Jonathan, I
    Calimlim, Brian M.
    Liu, Yingyi
    Platt, Andrew
    Thyssen, Jacob P.
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 188
  • [7] Aggregate Response Benefit in Skin Clearance and Itch Reduction With Upadacitinib or Dupilumab in Patients With Moderate-to-Severe Atopic Dermatitis
    Silverberg, Jonathan I.
    de Bruin-Weller, Marjolein
    Calimlim, Brian M.
    Hu, Xiaofei
    Ofori, Sarah A.
    Platt, Andrew M.
    Teixeira, Henrique D.
    Eyerich, Kilian
    Thyssen, Jacob P.
    DERMATITIS, 2024, 35 (03) : 266 - 274
  • [8] Efficacy and Safety of Upadacitinib vs Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis A Randomized Clinical Trial
    Blauvelt, Andrew
    Teixeira, Henrique D.
    Simpson, Eric L.
    Costanzo, Antonio
    De Bruin-Weller, Marjolein
    Barbarot, Sebastien
    Prajapati, Vimal H.
    Lio, Peter
    Hu, Xiaofei
    Wu, Tianshuang
    Liu, John
    Ladizinski, Barry
    Chu, Alvina D.
    Eyerich, Kilian
    JAMA DERMATOLOGY, 2021, 157 (09) : 1047 - 1055
  • [9] Efficacy of upadacitinib and dupilumab on achieving stringent and composite skin and itch outcomes: an indirect comparison of adults with moderate-to-severe atopic dermatitis
    Armstrong, April W.
    Hong, H. Chih-Ho
    Calimlim, Brian M.
    Buessing, Marric G.
    Crowell, Marjorie M.
    Silverberg, Jonathan, I
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 190 : II26 - II27
  • [10] Efficacy of Upadacitinib and Dupilumab on Achieving Stringent and Composite Skin and Itch Outcomes: an Indirect Comparison of Adults with Moderate-to-Severe Atopic Dermatitis
    Armstrong, April W.
    Hong, H. Chih-Ho
    Calimlim, Brian M.
    Buessing, Marric G.
    Crowell, Marjorie M.
    Silverberg, Jonathan I.
    DERMATOLOGY AND THERAPY, 2024, 14 (09) : 2457 - 2465
12345